CPT® 86362, Under Qualitative or Semiquantitative Immunoassays

The Current Procedural Terminology (CPT®) code 86362 as maintained by American Medical Association, is a medical procedural code under the range - Qualitative or Semiquantitative Immunoassays.

Subscribe to Codify by AAPC and get the code details in a flash.


Code 86362 describes a test to identify an antibody to myelin oligodendrocyte glycoprotein (MOG–IgG1), typically in a serum specimen. The lab method for this test is cell–based immunofluorescence assay (CBA). Clinicians may order this test following a negative aquaporin–4 antibody test to help distinguish neuromyelitis optica (NMO) from a similar condition characterized by the presence of MOG–IgG1, which is often called MOG–encephalomyelitis (MOG–EM).

For clinical responsibility, terminology, tips and additional info
start codify free trial.

View any code changes for 2024 as well as historical information on code creation and revision.
Combat the #1 denial reason - mismatched CPT-ICD-9 codes - with top Medicare carrier and private payer accepted diagnoses for the chosen CPT® code.
View the CPT® code's corresponding procedural code and DRG. In a click, check the DRG's IPPS allowable, length of stay, and more. To plug inpatient facility revenue drains, subscribe to DRG Coder today.
Crosswalk to an anesthesia code and its base units, and calculate payments in a snap! Subscribe to Anesthesia Coder today.
View matching HCPCS Level II codes and their definitions.


Have a question about CPT Code 86362 ? Start a discussion here